SEC and Drugmaker Allergan Reach Settlement over M&A Disclosure Violations

M&A Reporting, CTFN

Jonathan Spitzer

M&A Reporting

CTFN

Bringing the marketplace leading coverage of mergers, events, and major corporate actions, CTFN has a team of seasoned reporters from Los Angeles to London, publishing news that advances stories that matter to event-driven investors and deal professionals.

Event-Driven

<p>Despite a backlog of public comments, the Internal Revenue Service is racing to finalize its proposed rules on earnings stripping by mid-October, lest the election of Republican Donald Trump upsets the Obama administration’s efforts to rein in tax inversions.</p>

Despite a backlog of public comments, the Internal Revenue Service is racing to finalize its proposed rules on earnings stripping by mid-October, lest the election of Republican Donald Trump upsets the Obama administration’s efforts to rein in tax inversions.

Allergan Plc

IRS Races to Complete Inversion Rules